| Neuroendocrine Tumor studied in …STUDIED_INderived200 of 805show all (up to 200) |
|---|
| → studied in | NCT00001276recruiting Diagnosing and Treating Low Blood Sugar Levels · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00646022recruiting Natural History of Familial Carcinoid Tumor · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03412877Phase 2 · recruiting Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04086485Phase 1/Phase 2 · recruiting Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET) · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05196087recruiting Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!) · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06406465Phase 2 · recruiting A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07733024Phase 2 · recruiting Comparing DLL3 PET/CT to Standard Scans in Neuroendocrine Cancer · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04924075Phase 2 · recruiting Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015) · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Bladder Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05237934recruiting Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC) · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05773274Phase 2 · recruiting Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial · condition mapped CURATED_BROADER · 805 trials mapped (242 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03967951completed CT Radiomic Features of Pancreatic Neuroendocrine Neoplasms · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00001452completed Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00001595recruiting An Investigation of Pituitary Tumors and Related Hypothalmic Disorders · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Lactotroph Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03375320Phase 3 · active not recruiting Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07835412recruiting A Comparative Study of Patients Undergoing Surgery for Pituitary Neuroendocrine Tumors Detected by Different Ways · condition mapped CURATED_BROADER · 805 trials mapped (242 active) | — | — | Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03950609Phase 2 · active not recruiting Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors · condition mapped CURATED_BROADER · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04234568Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine Tumors · condition mapped CURATED_BROADER · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04665739Phase 2 · recruiting Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors · condition mapped CURATED_BROADER · 805 trials mapped (242 active) | — | — | Lung Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06878664Phase 3 · recruiting Randomized Interval Assessment Trial of Lu177-Dotatate in Slowly Progressive G1-2 Advanced Midgut Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07817225active not recruiting Optimizing Risk Assessment Through cfDNA in Pancreatic Neuroendocrine Tumors for Clinical Evaluation · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04104529NA · recruiting Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06263088NA · recruiting EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer. · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07087054Phase 3 · recruiting Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07165132Phase 1 · recruiting Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs. · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03074513Phase 2 · active not recruiting Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01039922terminated SwissNET - a Registry for Neuroendocrine Tumours in Switzerland · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06784752Phase 3 · recruiting Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02496208Phase 1 · active not recruiting Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Bladder Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06345079Phase 2 · recruiting Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06943755Phase 2/Phase 3 · recruiting Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07813351Phase 3 · not yet recruiting PRESTO: A Phase III Randomised Controlled Trial of Dose-escalated Proton Beam Therapy Versus Standard of Care Radiotherapy for Functioning Pituitary Tumours · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07808879NA · recruiting Comparison of [68Ga]Ga-HBED-CC-PEG6-Exendin-4 and [68Ga]Ga-HBED-CC-Exendin-4 PET/CT for Insulinoma Localization · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07809178not yet recruiting China Treatment Trial for Tumor in Sellar Region With Unruptured Intracranial Aneurysm · condition mapped CURATED_BROADER · 805 trials mapped (242 active) | — | — | Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06344507recruiting Iconographic Registry of Pancreatobiliary Endoscopy Procedures · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06725693recruiting Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03145857Phase 1/Phase 2 · terminated A Study to Evaluate a New Way to Identify/Diagnose Tumours With Somatostatin Receptors Using [68]Ga-HA-DOTATATE and to Ensure it is Safe to Use · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05687123Phase 1 · recruiting Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors · condition mapped CURATED_BROADER · 805 trials mapped (242 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05247905Phase 2 · active not recruiting Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors, the ComPareNET Trial · condition mapped CURATED_BROADER · 805 trials mapped (242 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07314164recruiting Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00569127Phase 3 · active not recruiting Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00923026enrolling by invitation Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01841736Phase 2 · active not recruiting Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors · condition mapped CURATED_BROADER · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03457948Phase 2 · completed Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases · condition mapped PROBABILISTIC · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05168631completed Multicenter Retrospective Database on Prognostic and Predictive Factors in Patients With Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06577987Phase 1 · active not recruiting Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02568267Phase 2 · active not recruiting Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03206060Phase 2 · recruiting Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05997056Phase 2 · completed Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03012789NA · completed Surgical Intervention and the NETest · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05064150active not recruiting Neuroendocrine Tumors - Patient Reported Outcomes · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07274657NA · recruiting Superb Microvascular Imaging (SMI) and Two-Dimensional Endoscopic Ultrasound Guided Shear Wave Elastography (2D-SWE-EUS) in Differential Diagnosis of Pancreatic Adenocarcinoma (PA) From Other Pancreatic Solid Lesions (PSLs) and Pancreatic neuroendocrinE Tumors (pNETs) Malignancy · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03728361Phase 2 · completed Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06427798Phase 1/Phase 2 · recruiting Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06479811Phase 1 · recruiting [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07620574Phase 3 · enrolling by invitation Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04609592Phase 1 · active not recruiting Study of PRRT in Metastatic, WHO Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07759960NA · recruiting Underwater Endoscopic Mucosal Resection Versus Endoscopic Submucosal Dissection for the Treatment of Small Rectal Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Rectal Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04993261early Phase 1 · active not recruiting An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05262556Phase 1 · completed NP-101 (TQ Formula) With Nivolumab and Ipilimumab in Advanced or Metastatic Extra-pulmonary Neuroendocrine Carcinomas · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03049189Phase 3 · active not recruiting Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07151391Phase 2 · recruiting The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue) · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05443087NA · recruiting TARGETed Therapy Drug MONITOring in DIGestive Oncology · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05724108Phase 2 · active not recruiting Testing the Effectiveness of an Anti-cancer Drug, Triapine, When Used With Targeted Radiation-based Treatment (Lutetium Lu 177 Dotatate), Compared to Lutetium Lu 177 Dotatate Alone for Metastatic Neuroendocrine Tumors · condition mapped CURATED_BROADER · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07129252Phase 1/Phase 2 · recruiting A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07132645early Phase 1 · recruiting An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05263050Phase 2 · recruiting Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06038461Phase 1/Phase 2 · recruiting An Open, Single-center Clinical Study of Surufatinib Combined With Temozolomide and S-1 in the First-line Treatment of Advanced Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05005715Phase 2 · completed Effect of Dexmedetomidine on Quality of Recovery in Non-functioning Pituitary Adenoma Patients Undergoing Endoscopic Transsphenoidal Surgery · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Non-Functioning Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06448208active not recruiting Defining Response Criteria for PET Scans for People With Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05000294Phase 1/Phase 2 · recruiting Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06876532NA · recruiting Evaluation of the Inflammation-based Index as a Predictive Marker of Clinical and Radiological Response in Patients Treated With Lu-177 Oxodotreotide for Intestinal Neuroendocrine Tumour · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Intestinal Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07695532completed A Clinical Risk Score to Stratify High-risk PanNETs · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07635316recruiting A Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07684170Phase 2 · not yet recruiting Study of CTX-471 in Patients With Neural Cell Adhesion Molecule (NCAM) Positive Neuroendocrine Neoplasms · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07316101NA · recruiting Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07493447early Phase 1 · recruiting Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02012699recruiting Integrated Cancer Repository for Cancer Research · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06790706Phase 2 · active not recruiting IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07366658Phase 1 · recruiting Safety, Tolerability and Preliminary Efficacy of NEUK203-13 in Refractory Neuroendocrine Tumor Patients · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06016855Phase 4 · recruiting Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06122610Phase 1 · completed Using Novel Imaging to More Safely Treat Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03110978Phase 2 · active not recruiting Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Lung Neuroendocrine Tumor G2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07460232early Phase 1 · recruiting FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07661420Phase 1 · not yet recruiting 211At-MABG in Adults With Advanced Neuroendocrine Cancers · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Lung Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06041516Phase 1 · recruiting A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06091748Phase 3 · completed Gallium (68Ga) Edotreotide PET/CT for Imaging Patients With Gastrointestinal Pancreatic Neuroendocrine Tumors · condition mapped CURATED_BROADER · 805 trials mapped (242 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06158516Phase 2 · terminated A Study of Surufatinib as Adjuvant Therapy for Pancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06204159NA · active not recruiting Lipiodol Deposition Using Endhole vs. Pressure-Modulated Delivery · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06788886NA · recruiting Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02134639Phase 1 · completed PET-CT Imaging of Neuro-endocrine Tumors and Preliminary Clinical Evaluation · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04510311early Phase 1 · completed Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04339036Phase 2 · recruiting CapTemY90 for Grade 2/3 NET Liver Metastases · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04954820Phase 2 · recruiting Assessment of Retreatment With Lutathera® in Patients With New Progression of Intestinal Well-differenciated NET · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06607692Phase 1/Phase 2 · recruiting Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07612748NA · recruiting Two Different Endoscopic Treatments for Rectal Neuroendocrine Neoplasms · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Rectal Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07619417NA · not yet recruiting Endoscopic Ultrasound-Guided Pulsed Electric Field Ablation for the Treatment of Pancreatic Neoplasms · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07621146not yet recruiting A Comparison of [68Ga]DOTATATE and [18F]AmBF3TATE for the Staging and Assessment of Neuroendocrine Malignancies · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03935893Phase 2 · active not recruiting Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07618949NA · not yet recruiting Standardized Patient Education in Pituitary Surgery · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06430021recruiting Study of the Value of hPG80 (Circulating Progastrin) for the Diagnosis of Neuroendocrine Tumours in Patients With an MEN1 Mutation · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05884255Phase 3 · recruiting An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors. · condition mapped CURATED_BROADER · 805 trials mapped (242 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07595666NA · enrolling by invitation Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region. · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03910660Phase 1/Phase 2 · completed A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype. · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07591493Phase 3 · not yet recruiting Adjuvant Trial in Pancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02750371NA · completed Effect of Irradiation of the Cavernous Sinus and the Sellar Region on Autobiographical Memory · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05636618Phase 1/Phase 2 · recruiting Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05988918Phase 2 · active not recruiting Multicenter Trial of ESK981 in Patients With Select Solid Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06735560NA · recruiting Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NEN · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03583528active not recruiting DOTATOC PET/CT for Imaging NET Patients · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05918302Phase 3 · recruiting Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus. · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04848337Phase 2 · active not recruiting Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04888481Phase 2 · recruiting 68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04544098early Phase 1 · active not recruiting Lutathera in People With Gastroenteropancreatic (GEP), Bronchial or Unknown Primary Neuroendocrine Tumors That Have Spread to the Liver · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07554560NA · recruiting Nutrition Intervention for Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07568366early Phase 1 · not yet recruiting AI in Endoscopic Transsphenoidal Surgery · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04727723completed Italian Prospective Observational Study Assessing the Effectiveness and Outcomes Associated With Lutathera Treatment in GEP-NETs · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03465618Phase 1 · active not recruiting A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01744249Phase 2/Phase 3 · completed Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06889493Phase 1 · recruiting SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET) · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01916148available 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07165886Phase 2/Phase 3 · recruiting Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07247526NA · completed Effect of Foot Bath on Anxiety and Physiological Parameters · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02174549Phase 1/Phase 2 · recruiting Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04074135Phase 2 · recruiting Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05969860Phase 2 · recruiting At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer · condition mapped CURATED_BROADER · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07536087NA · recruiting Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Cystic Neoplasms and Pancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07534371active not recruiting Analysis of Optimal Treatment Sequencing of Surufatinib and Somatostatin Analogs in Neuroendocrine Tumors: A Retrospective Cohort Study · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05153772Phase 2 · active not recruiting Targeted Alpha-emitter Therapy of PRRT Naïve and Previous PRRT Neuroendocrine Tumor Patients · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06638931Phase 2 · recruiting Agnostic Therapy in Rare Solid Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04375267Phase 1 · completed 177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive Tumours · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05249114Phase 1 · active not recruiting Study of Cabozantinib With Lu-177 in Patients With Somatostatin Receptor 2 Positive Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04291885Phase 2 · active not recruiting Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04569591NA · recruiting DDAVP for Pituitary Adenoma · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05048901Phase 1/Phase 2 · recruiting Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06141369NA · recruiting Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001) · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05477576Phase 3 · recruiting Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06826170NA · completed Hypofractionated Radiosurgery to Treat Residual/Recurrent Non Secreting Pituitary Adenoma (HYPOADENO) · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05847855recruiting Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04074642NA · completed OCT-angiography as a Pronostic Marker for Visual Impairment in Patients Undergoing Neurosurgery for Compressive Macroadenoma : a Prospective Study. · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04804371NA · active not recruiting Dual Tracer (68Ga-DOTATATE and 18F-FDG) PET Imaging in G2 & G3 Gastroenteropancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04090034recruiting Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05361668Phase 2 · completed Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05411133Phase 1 · completed Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05500391Phase 2 · recruiting Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04119024Phase 1 · recruiting Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05746208Phase 2 · recruiting Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07463235Phase 3 · recruiting Safety and Potency of a High Cabergoline Dosage in Microprolactinomas · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Lactotroph Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07463872recruiting Management of Pancreatic Cystic Lesions Using Artificial Intelligence Based on EUS and Multimodal Data · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05160480enrolling by invitation A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00830557recruiting Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07456878Phase 1 · recruiting Use of [18F] Fluoroethyl-L-tyrosine PET/MRI for Identifying Small Functional Pituitary Adenomas · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07450287not yet recruiting CardioNETPOL National Registry of Carcinoid Heart Disease · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07446036active not recruiting Prediction Model for Postoperative Headache After Transsphenoidal Pituitary Surgery · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03211988Phase 2 · terminated Entinostat Neuroendocrine (NE) Tumor · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07150546Phase 1 · recruiting Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors. · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04969887Phase 2 · active not recruiting Combination Immunotherapy in Rare Cancers Under InvesTigation · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07439757recruiting AI-Powered Precision Decision-Making for Pancreatic Diseases · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01824875Phase 2 · active not recruiting Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Gastrin-Producing Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04907643NA · recruiting Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04278118NA · recruiting Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04365023completed Cohort of Well-differentiated Grade 3 Neuroendocrine Digestive Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04711135Phase 2 · active not recruiting Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07404176Phase 2 · recruiting Study to Assess the Safety and Effectiveness of Novel Radiopharmaceutical Terbium-161 DOTATATE in Metastatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04706910Phase 3 · recruiting 18F-DOPA II - PET Imaging Optimization · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03879694Phase 1 · completed Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Lung Neuroendocrine Tumor G2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06055439Phase 1/Phase 2 · recruiting A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07373015NA · not yet recruiting Modified Double Snare Assisted EMR (mDS-EMR) VS ESD for Rectal Neuroendocrine Tumors Smaller Than 1cm · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Rectal Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07369505Phase 1 · recruiting Sapu003 in Advanced mTOR-sensitive Solid Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05556473Phase 1 · recruiting F-Tryptophan PET/CT in Human Cancers · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07268183recruiting How Estrogen Fluctuations Before Diagnosis Affect the Size Prolactin-secreting Tumors · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Lactotroph Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07273409NA · recruiting Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02826928NA · completed Diagnostic Performances of Urine and Plasma 5-hydroxyindolacetic Acid (5HIAA) Values in Patients With Small-intestine Neuroendocrine Tumors · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04505553Phase 2 · completed Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07328607NA · recruiting Outcomes After Laparoscopic Versus Open Pancreaticoduodenectomy · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06356467recruiting Influence of Tumour and Patient's Related Factors on the Response to Medical Treatments in Well Differentiated GEP-NENs · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07340437completed Clinical Study of 18F-Exendin-4 in Insulinoma · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03891784Phase 2 · active not recruiting Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04362436Phase 2 · completed TheraSphere Selective Internal Radiation Therapy (SIRT) as Treatment for Neuroendocrine Tumours With Liver Mets · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05987176Phase 2 · terminated Comparison of Adjuvant Treatment With 177Lu-DOTATATE to Best Supportive Care in Patients After Resection of Neuroendocrine Liver Metastases · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06232564Phase 2 · active not recruiting A Study of Etoposide-carboplatin in Combination With Pembrolizumab and Lenvatinib Maintenance in HG-NETs · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05735912NA · active not recruiting EUS-RFA Versus Surgery for Pancreatic Insulinoma (ERASIN-RCT) · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Pancreatic Insulinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06406387active not recruiting ATRX/DAXX in EUS-FNB Specimens of Pan-NETs · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07335315recruiting Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06663072Phase 1 · recruiting Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors · condition mapped CURATED_BROADER · 805 trials mapped (242 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06936813active not recruiting The PROMISE Survey · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Lactotroph Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06584123NA · recruiting Molecular Pituitary Imaging Using 18F-FET PET · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Pituitary Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07317713completed A Two-decade Mortality Risk Analysis of Gastrointestinal Carcinoid Neoplasms: an Updated SEER-based Study 2000-2022 · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07317726completed Recent Trends in Stage Migration of Gastrointestnial Carcinoid Tumors Over Two Decades: a Retrospective SEER-based Analysis 2000-2022 · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07102056not yet recruiting 18F-AlF-NOTA-Octreotide PET in Neuroendocrine Neoplasms · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07302100recruiting Nutritional Status Assessment in Adult Patients Followed for Gastroenteropancreatic Neuroendocrine Tumors at Strasbourg University Hospital · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Digestive System Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03600233Phase 2 · active not recruiting Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03691064active not recruiting Post-Authorization Long-Term Safety Study of LUTATHERA · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03290079Phase 2 · completed Phase II Study of Pembrolizumab and Lenvatinib in Advanced Well-differentiated Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07272512Phase 4 · recruiting Prospective Multicenter Real-world Study of Surufatinib in Patients With Advanced Neuroendocrine Neoplasms · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07291752completed The Risk of Second Primary Gastrointestinal Malignancies Following Primary Gastrointestinal Carcinoid Tumors: a SEER Based Study 2000-2022 · condition mapped ALIAS · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06926634Phase 2 · recruiting Zanzalintinib Maintenance in Patients With High Grade Neuroendocrine Neoplasms (HG-NENs) · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05040360Phase 2 · recruiting Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Pancreatic Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06943521Phase 1/Phase 2 · recruiting A Study of MT-4561 in Patients With Various Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 805 trials mapped (242 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |